Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:00 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 1,393 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Emergency Room Clear all

Conditions: Non-Alcoholic Fatty Liver Disease, Steatosis of Liver, Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions: STIRRED; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 4,704 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Small Bowel Obstruction, Gastrointestinal Hemorrhage
Interventions: RightSpot pH Indicator, Chest radiograph; Device · Radiation
Lead sponsor: RightBio Metrics; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Severe Sepsis, Septic Shock
Interventions: Modified EGDT, Standard EGDT; Procedure
Lead sponsor: National Institute of General Medical Sciences (NIGMS); NIH
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 3
States / cities: Boston, Massachusetts • Camden, New Jersey • Charlotte, North Carolina

Conditions: Alcohol Abuse
Interventions: Brief Negotiated Interview, General Health Information; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 65 Years and older
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Adolescent Behavior, Emergency Department, Abuse Physical, Abuse Mental, Abuse Verbal, Abuse Domestic, HEART, Intimate Partner Violence
Interventions: ED-HEART; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 19 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Stroke, Acute
Interventions: Trans-Sodium Crocetinate, Placebo; Drug · Other
Lead sponsor: Diffusion Pharmaceuticals Inc; Industry
Eligibility: 40 Years to 85 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Los Angeles, California • Charlottesville, Virginia

Conditions: Falls-Risk
Interventions: Falls-Risk Clinical Decision Support (CDS) Tool; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 65 Years and older
Enrollment: 36,205 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Rockford, Illinois • Madison, Wisconsin

Conditions: Blindness
Interventions: Egress Badge; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Atrial Fibrillation, Atrial Flutter
Interventions: Oral, Intravenous drug; Drug
Lead sponsor: Corewell Health South; Other
Eligibility: 18 Years and older
Enrollment: 444 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Saint Joseph, Michigan

Conditions: Language Discordance
Interventions: Professional medical interpreter; Behavioral
Lead sponsor: Mathematica Policy Research, Inc.; Other
Eligibility: Not listed
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Freehold, New Jersey • New Brunswick, New Jersey

Conditions: Sepsis
Interventions: Fluid Resuscitation, Standard of Care; Other
Lead sponsor: Cheetah Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 12
States / cities: Birmingham, Alabama • Sacramento, California • Denver, Colorado + 7 more

Conditions: Reversal of Coagulopathy
Interventions: Beriplex® P/N (Kcentra), Fresh frozen plasma; Biological
Lead sponsor: CSL Behring; Industry
Eligibility: 18 Years and older
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 16
States / cities: Newark, Delaware • Lexington, Kentucky • Boston, Massachusetts + 13 more

Conditions: EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer
Interventions: Datopotamab deruxtecan; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years and older
U.S. locations: 14
States / cities: Springdale, Arkansas • Honolulu, Hawaii • Bowling Green, Kentucky + 10 more

Conditions: Heart Diseases
Interventions: Ultrasound and Educational Intervention, Educational Intervention Alone; Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 45 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Kidney Stones, Ureteral Stones
Interventions: Tamsulosin, Placebo; Drug
Lead sponsor: Robert Swor; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: ACS (Acute Coronary Syndrome)
Interventions: Abbott i-STAT point of care (POC) device; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: Charlotte, North Carolina • High Point, North Carolina • Winston-Salem, North Carolina

Conditions: Opioid Use Disorder
Interventions: SUN, SUN + Telebridge, ED-ITT, ED-ITT + BHS; Behavioral
Lead sponsor: RAND; Other
Eligibility: 18 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Colton, California

Conditions: Dyspnea
Interventions: Not listed
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 89 Years
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Contraception
Interventions: Emergency contraception website, Emergency contraception video; Other
Lead sponsor: Planned Parenthood League of Massachusetts; Other
Eligibility: 18 Years to 29 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Activities, Mental Health Issue, Life Style
Interventions: WHOQOL-BREF survey; Other
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: HIV, HIV Infections
Interventions: Video, in-person HIV pre-test counseling; Behavioral
Lead sponsor: North Bronx Healthcare Network; Other
Eligibility: 15 Years to 21 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Emergency Coughing
Interventions: 5% Lidocaine Ointment, Water-Based Lubricant; Drug · Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 212 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome
Interventions: Infusion of 200% maintenance fluids as balanced crystalloid IV solution, Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution; Other
Lead sponsor: University of Calgary; Other
Eligibility: 9 Months to 21 Years
Enrollment: 1,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 19 more

Conditions: COVID19
Interventions: Nitric Oxide Gas, Inhaled Supplemental Oxygen; Drug · Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the ED

Nasogastric/Orogastric Tube Placement Verification Study Using RightSpot pH Indicator to Verify Gastric Acidity

Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation

Study of an Emergency Department-based Intervention to Reduce Alcohol Misuse in Older Adults

Emergency Department Healthcare Education Assessment and Response for Teen Relationships: A Pilot Feasibility Study

Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

Effectiveness of an Automated Falls-Risk Screening and Referral Tool in the Emergency Department (ED)

Emergency Egress and Information System for Persons With Vision Loss

Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation

Cost Effectiveness of Language Services in Hospital Emergency Departments (EDs)

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

An Open-label, Randomized, Multicenter Phase IIIb Study to Assess the Efficacy, Safety and Tolerance of BERIPLEX® P/N (Kcentra) Compared With Plasma for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Subjects Requiring an Urgent Surgical Procedure

Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients

Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department

Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath

Targeted Video Messaging About Emergency Contraception

Effects of the COVID-19 Health Emergency on Biopsychosocial Health

Video-based Counseling & Rapid HIV Testing for Teens

ENDOTRACHEAL Tube LIDOCAINE

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection

Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED